Usually not for weight loss. Harvard Pilgrim said most of its 2026 plans exclude weight-loss drugs, including GLP-1s like Zepbound. Coverage survives only on two formularies, Value and Premium, where Zepbound needs prior authorization and, for most new starters, a 6-month program first. Your employer's plan decides which list you're on.
So the useful question is "which formulary is my plan on, and if it's an excluded one, what's the cheapest honest path?" Below: how to find out, what Harvard Pilgrim's criteria say, and what Zepbound costs without coverage.
The quick answer by Harvard Pilgrim plan type
| Your Harvard Pilgrim plan | Does it cover Zepbound for weight loss? | What decides it |
|---|---|---|
| Individual or small-group plan (Core formulary, ConnectorCare) | No. Weight-loss drugs are excluded | The formulary |
| Large-group plan moved to the Select formulary | No. Select excludes all weight-loss coverage | The formulary |
| Large-group plan on the Premium or Value formulary | Yes, with prior authorization (PA), if your plan includes weight-loss coverage | Your employer's buy-up and PA approval |
| Self-insured employer plan | Depends on your employer's benefit document | Your employer's choices |
| Medicare | Not through Harvard Pilgrim commercial rules. See the Medicare section below | Medicare's GLP-1 Bridge rules |
Sources: Point32Health provider notice, December 2025; Harvard Pilgrim drug coverage update, September 2025. Checked November 9, 2026.
These changes don't affect GLP-1s prescribed for type 2 diabetes. If you have diabetes, Mounjaro and similar drugs follow separate rules.
The right next step depends on your formulary, your BMI and health history, and whether you'd pay cash while you sort out coverage. The RX Index's Find My GLP-1 Path tool asks a few quick questions and shows the GLP-1 paths and providers that fit your goals, budget, insurance and situation.
See which GLP-1 path fits your Harvard Pilgrim plan
What changed on January 1, 2026
Harvard Pilgrim told its provider network in 2025 that most plans would stop covering weight-loss medications. The December 2025 notice spells out who is affected:
| Plan group | What the notice says |
|---|---|
| Individual, small-group and merged-market plans on the Core MA, NH, ME and RI formularies, plus ConnectorCare | Weight-loss drugs excluded from January 1, 2026. In Core NH, Core ME and Core RI, "alternative indication" uses are now excluded too |
| Large-group plans in MA, NH, ME and RI | Moved to a new Select formulary that "excludes all weight loss medication coverage," starting January 1, 2026 or the group's anniversary date |
| Some large commercial groups | Can buy up to a Premium formulary that includes weight-loss drugs, with Zepbound as the preferred weight-loss GLP-1 |
| Plans on the Value or Premium formulary | Weight-loss coverage remains, with GLP-1s and Contrave subject to PA |
Source: Point32Health provider notice, December 2025, checked November 9, 2026.
Two details matter if you already had Zepbound. First, the notice says members previously approved for a weight-loss drug had their authorization end on January 1, 2026 or at the group anniversary, with no grandfathering. Second, Harvard Pilgrim said it would notify affected members by letter at least 60 days ahead. If you got that letter, your plan is probably on an excluded formulary.
How to find out which formulary you're on
Harvard Pilgrim says to check your plan's formulary to see whether weight-loss coverage exists, and that 2026 formulary choices can change when your group renews. Check in this order:
- Look at your 2026 plan materials from your employer or Harvard Pilgrim. The formulary name (Core, Select, Value, Premium or ConnectorCare) is usually printed there.
- Log in to your Harvard Pilgrim member account and search the drug list for Zepbound.
- Call Member Services at the number on your ID card. Ask: "Does my plan include weight-loss medication coverage, and is Zepbound covered with prior authorization?"
- Ask HR if your plan comes through work. Employers choose the formulary.
Say you're 41, work at a 150-person Massachusetts company, and your employer renewed in January. If your card now shows a Select formulary, Zepbound for weight loss is excluded, and no prior authorization or appeal can change a benefit your employer didn't buy. If your employer bought up to Premium, you're in the next section.
If you'd rather compare options before making calls, Ro offers a free insurance check. Ro's insurance help applies to the Wegovy pen, Zepbound autoinjector pen and Ozempic. The Zepbound KwikPen, which is what Ro's cash prices below refer to, isn't part of that insurance process (Ro insurance).
Check whether your plan covers a GLP-1 with Ro (sponsored affiliate link, opens in a new tab)
If you're on a Premium or Value formulary: Harvard Pilgrim's Zepbound criteria
Harvard Pilgrim and Tufts Health Plan commercial plans use one Pharmacy Medical Necessity Guideline for weight-loss drugs, effective July 1, 2026. For Zepbound, it asks for all of these on a first approval:
- You're 18 or older.
- Your BMI is 30 or higher, or 27 to 29 with at least one weight-related condition: diabetes, high blood pressure, sleep apnea, high cholesterol, symptomatic knee or hip osteoarthritis, acid reflux (GERD), or heart disease shown by bypass surgery, a heart attack, stroke or angina.
- Zepbound is used along with lifestyle changes such as diet, exercise or behavioral support.
- If your plan requires it (Value, Premium and some self-funded plans), you've completed 6 months of the plan-specified behavior program.
Source: Harvard Pilgrim and Tufts Health Plan Weight Loss Medications guideline, effective July 1, 2026, checked November 9, 2026.
The 6-month program rule
For fully insured Harvard Pilgrim plans that keep weight-loss coverage, members newly seeking a weight-loss GLP-1 must take part in a 6-month behavior-modification program called ResetStrong, which includes coaching from registered dietitians. The notice says this applies to people newly starting, not to people already on the drug. For self-insured employers, the program is offered as an option. Harvard Pilgrim's utilization team says whether the program applies when it reviews your PA.
The guideline adds a catch that surprises people: if you start Zepbound on your own by paying cash, using samples or a free offer, that doesn't count as an established response. Your request is reviewed as a first approval, program included. Members new to the plan who are already stable on Zepbound are reviewed against the renewal criteria instead.
Approval length and renewals
| Step | What Harvard Pilgrim's guideline says |
|---|---|
| First approval | Up to 6 months |
| Renewal | Up to 1 year at a time |
| Renewal test | At least 5% of starting weight lost, or that loss maintained, during the first 6 months, with baseline and follow-up weights submitted |
| Also required | Your prescriber documents that you're keeping up lifestyle changes |
| Not allowed | Using Zepbound with another anti-obesity drug; any GLP-1 or compounded product not FDA-approved for weight loss |
Source: Weight Loss Medications guideline, checked November 9, 2026.
The last row matters. Harvard Pilgrim won't authorize compounded GLP-1 products. Compounded tirzepatide isn't FDA-approved, and nothing on this page recommends it.
Your Harvard Pilgrim Zepbound PA checklist
| Item | Why Harvard Pilgrim asks for it |
|---|---|
| Confirmation your plan has weight-loss coverage | Without it, PA can't help |
| Starting height, weight and BMI | Sets the BMI 30 (or 27 plus a condition) test |
| A listed weight-related condition (if BMI is 27 to 29) | Needed for the lower BMI tier |
| Proof of 6 months in the plan's program, if required | A first-approval requirement on Value, Premium and some self-funded plans |
| For renewal: dated weights before and during Zepbound | The 5% test |
Prior authorization is a permission slip: your prescriber gets Harvard Pilgrim's OK before the pharmacy can bill your plan.
Zepbound for sleep apnea
Harvard Pilgrim's guideline has a separate Zepbound path for moderate-to-severe obstructive sleep apnea in adults with obesity: a sleep study showing an apnea-hypopnea index of 15 or more events an hour, a BMI of 30 or higher, lifestyle changes, and either CPAP counseling or a reason you can't use CPAP. Renewal asks for a positive response and a maintenance dose of 5 to 15 mg weekly.
That pathway sits inside the same plan-coverage limit as the weight-loss one: the guideline says weight-loss medications are covered only if your plan includes the benefit. The December 2025 notice also says some formularies exclude "alternative indications," and it doesn't separately name sleep apnea. Ask Member Services whether your formulary applies the sleep apnea pathway. More: does insurance cover Zepbound for sleep apnea.
What Zepbound costs without Harvard Pilgrim coverage
If your plan covers Zepbound, you pay your copay or coinsurance. Lilly says people with commercial insurance that covers Zepbound may pay as low as $25 for a one- or three-month supply of single-dose pens, and governmental beneficiaries are excluded (Lilly Zepbound cost information). See Zepbound savings card.
If your plan excludes it, you're paying cash. Ro's cash prices for the Zepbound KwikPen match LillyDirect, NovoCare and TrumpRx, according to Ro (Ro pricing, checked November 9, 2026).
| Zepbound KwikPen dose | Ro cash price per month |
|---|---|
| 2.5 mg | $299 |
| 5 mg | $399 |
| 7.5 mg | $449 with manufacturer offer |
| 10 mg to 15 mg | $449 with manufacturer offer |
Source: Ro pricing, checked November 9, 2026. Prices and offers can change.
Ro's membership is a separate cost: $39 the first month (refunded if you're not eligible), then $74 to $149 a month depending on plan length, with $74 on a 12-month plan paid upfront. So a first month on 2.5 mg would be $299 + $39 = $338, and an ongoing month at 5 mg on the monthly plan would be $399 + $149 = $548.
Compare more routes in cheapest Zepbound without insurance, Zepbound cost with insurance and how to get Zepbound KwikPen online.
See Ro's Zepbound KwikPen cash prices (sponsored affiliate link, opens in a new tab)
If Harvard Pilgrim denies or excludes Zepbound
Read the letter for one thing: is it a denial or an exclusion? A denial means a criterion wasn't met or documented. An exclusion means your plan doesn't include weight-loss drugs.
If it's a denial: ask your prescriber what was missing. Common gaps are the BMI record, the weight-related condition, or proof of the 6-month program. They can resubmit or appeal (how to appeal a Zepbound denial; GLP-1 appeal levels explained).
If it's an exclusion: an appeal on medical grounds usually won't add a benefit your employer didn't buy. You can ask HR whether the group can move to a formulary with weight-loss coverage when it renews (how to ask your employer to cover a GLP-1), or compare cash prices above.
Tufts, Medicare and other plans
Tufts Health Together (MassHealth) members: this isn't a Harvard Pilgrim plan. Tufts says that since July 1, 2026 it no longer covers Wegovy or Zepbound for obesity, keeps GLP-1 coverage for heart disease, MASH liver disease and moderate-to-severe sleep apnea with a new PA, and prefers Wegovy over Zepbound (Tufts MassHealth notice). Ro says Medicaid patients aren't currently eligible for its program.
Medicare: Medicare's GLP-1 Bridge covers the Zepbound KwikPen only (not single-dose vials or pens) for a $50 copay per one-month supply if you meet its BMI rules. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease aren't eligible for the Bridge, but their Part D plan might cover a GLP-1 (Medicare.gov). See the Medicare GLP-1 Bridge program.
Which path fits you
| If you… | Your best next step |
|---|---|
| Don't know which formulary your plan uses | Check your plan materials, member portal or call Member Services |
| Are on Core, Select or ConnectorCare | Plan for cash prices or ask HR about a different formulary at renewal |
| Are on Premium or Value and meet the BMI test | Ask your prescriber to submit the PA and ask about the 6-month program |
| Started Zepbound on your own and then got coverage | Expect the first-approval review, including any program requirement |
| Have sleep apnea confirmed by a sleep study | Ask whether your formulary applies the sleep apnea pathway |
| Have Medicare | Ask about the Bridge (KwikPen, $50 a month) |
Safety before you ask Harvard Pilgrim
Do not use Zepbound if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Zepbound has a boxed warning about thyroid C-cell tumors. Tell your prescriber if you're pregnant or planning a pregnancy. Get care right away for severe stomach pain that won't go away (Zepbound prescribing information, revised August 2026).
What we actually verified
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
On November 9, 2026, we:
- Read Point32Health's December 2025 notice on weight-loss medication coverage and Harvard Pilgrim's September 2025 member update.
- Read the Harvard Pilgrim and Tufts Health Plan Weight Loss Medications guideline effective July 1, 2026, including the Zepbound weight-loss and sleep apnea criteria.
- Read Tufts' May 2026 MassHealth notice, Medicare.gov's Bridge page, Lilly's Zepbound cost page, the Zepbound prescribing information, and Ro's pricing and insurance pages.
What we could not confirm: which formulary your specific employer uses, whether your formulary applies the sleep apnea pathway, Harvard Pilgrim's Medicare plans, your copay, and the ResetStrong program's own enrollment page. Only Harvard Pilgrim or your employer can tell you those. No web page, including this one, can tell you whether you'll be approved. Harvard Pilgrim decides, based on what your prescriber sends.
Frequently asked questions
Does Harvard Pilgrim cover Zepbound for weight loss?
Usually not. Harvard Pilgrim said most 2026 plans exclude weight-loss drugs. Coverage remains on the Value and Premium formularies with prior authorization, and only if your plan includes the benefit.
Which Harvard Pilgrim formularies exclude Zepbound?
Core, Select and ConnectorCare exclude weight-loss medication coverage, according to Point32Health's December 2025 notice.
What BMI does Harvard Pilgrim require for Zepbound?
A BMI of 30 or higher, or 27 to 29 with at least one weight-related condition such as high blood pressure, sleep apnea, high cholesterol or heart disease. You also need to use Zepbound along with lifestyle changes.
What is the ResetStrong program?
It's a 6-month behavior-modification program with dietitian coaching. Fully insured Harvard Pilgrim plans with weight-loss coverage require it for members newly starting a weight-loss GLP-1. It's optional for self-insured employers.
Does Harvard Pilgrim cover compounded tirzepatide?
No. Harvard Pilgrim's guideline says it won't authorize a GLP-1 or compounded product that isn't FDA-approved for weight loss. Compounded tirzepatide isn't FDA-approved.
How long does a Harvard Pilgrim Zepbound approval last?
The first approval is up to 6 months. Renewals are up to 1 year if you've lost or kept off at least 5% of your starting weight and keep up lifestyle changes.
Does Harvard Pilgrim cover Zepbound for sleep apnea?
Its guideline has a sleep apnea pathway for adults with an AHI of 15 or more and a BMI of 30 or higher, but your plan must include weight-loss medication coverage. Ask Member Services how your formulary handles it.
Can Ro help me pay for Zepbound if Harvard Pilgrim excludes it?
Ro sells the Zepbound KwikPen for cash at the prices above, plus its membership. Ro's insurance concierge covers the Zepbound autoinjector pen, Wegovy pen and Ozempic, not the KwikPen, and can't add a missing benefit.
Sources
- Harvard Pilgrim / Point32Health: December 2025 provider notice; September 2025 drug coverage update; Weight Loss Medications guideline, effective July 1, 2026; Tufts MassHealth notice, May 2026 (all checked November 9, 2026)
- Medicare.gov: weight-loss drugs and the GLP-1 Bridge (checked November 9, 2026)
- Lilly: Zepbound cost information and Zepbound prescribing information (revised August 2026; checked November 9, 2026)
- Ro: pricing and insurance (checked November 9, 2026)
Related: does Blue Cross cover Zepbound, does marketplace insurance cover Zepbound, insurance stopped covering Zepbound, does Medicaid cover Zepbound.
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.